BriaCell Therapeutics Corp.

Develops off-the-shelf cellular immunotherapies for advanced breast, prostate, and lung cancers.

BCTX | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Website:: https://briacell.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

BriaCell Therapeutics Corp. is a clinical-stage immuno-oncology company developing targeted cellular immunotherapies to activate the patient's immune system against cancer. Its lead candidate, Bria-IMT™, is a patented, off-the-shelf cell-based therapy in a pivotal Phase 3 study for advanced metastatic breast cancer. Bria-IMT™ has received FDA Fast Track designation and has shown efficacy in heavily pre-treated patients, including those with central nervous system metastases. The company is also advancing its next-generation Bria-OTS™ platform, which provides personalized, off-the-shelf treatments matched to a patient's HLA type. The Bria-OTS™ platform is being evaluated in a Phase 1/2 clinical trial for multiple cancers, including breast, prostate, and lung cancer.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BriaCell Therapeutics Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BriaCell Therapeutics Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for BriaCell Therapeutics Corp. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Global CRO for pharma & biotech, offering research models, safety testing & manufacturing solutions.	United States of America	CRL
Ch. Charilaou Group Plc A tour operator selling travel packages and developing online reservation platform solutions.	Cyprus	CHCH
Cheil Worldwide Inc Creates data-driven, integrated marketing and connected experiences for global brands.	South Korea	030000
Chiome Bioscience Inc. Clinical-stage biotech developing therapeutic antibodies and providing R&D services to partners.	Japan	4583
Chordia Therapeutics,Inc Developing first-in-class, small-molecule anti-cancer drugs targeting RNA deregulation.	Japan	190A
CHOSA Oncology AB Develops diagnostics and targeted therapies to personalize platinum-based cancer treatments.	Sweden	CHOSA
Cidara Therapeutics, Inc. Developing drug-Fc conjugates as targeted immunotherapies for cancer and serious infections.	United States of America	CDTX
CINC Corp. Offers AI marketing analytics and SEO tools leveraging a vast Japanese keyword dataset.	Japan	4378
CIRCULATION Co.,Ltd. Connects corporations with experts for project-based consulting to solve business challenges.	Japan	7379
CIZZLE BIOTECHNOLOGY HOLDINGS PLC Developing a CIZ1B biomarker blood test for the early detection of lung cancer.	United Kingdom	CIZ